Analysts expect NRx Pharmaceuticals to post earnings of ($0.30) per share for the quarter. NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) last posted its earnings results on Friday, March 14th.

NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports.

Nissan teased a boxy electric SUV due in late 2027, and we think this could serve as an indirect successor to the Xterra. While it may not end up using the Xterra name, Nissan described the SUV as ...

Nissan has had a rocky couple of years, but things really began to spiral downward for the Japanese automaker in the second half of 2024. It was then that Nissan executives stated the brand likely ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in a listen only mode. Following the presentation ...

A much-anticipated model, the all-new 2026 Nissan Leaf, will be unveiled in June, joining the Ariya in Nissan's small stable of EVs. The third-generation Leaf is being reinvented from a frumpy ...

Nissan has named Ivan Espinosa its new CEO, and he succeeds Makoto Uchida, who has held the position since 2019. Espinosa has been involved in Nissan's global product planning since 2010 and has ...

The rumors flying last week that Nissan CEO Makoto Uchida had one foot out the door have come true. On Tuesday, the Yokohama, Japan-based automaker announced the resignation of Uchida in the same ...

Nissan said Tuesday that Ivan Espinosa, its chief planning officer, would take the helm from April 1, ending weeks of speculation over who will succeed Makoto Uchida as leader of the troubled ...

Additionally on Monday, NRx Pharmaceuticals (NRXP) reported a FY24 loss per share of ($2.36), which compared to a loss per share of ($3.98) for the same period last year. As of December 31 ...

NRX-100 (IV, preservative-free ketamine)According to the CDC, more than 13 million adults contemplate suicide each year; NRX-100 – IV ketamine for Suicidal Depression - can help address this ...